secwatch.observer — SEC 8-K summary
======================================

Issuer:     Korro Bio, Inc. (KRRO)
CIK:        0001703647
Form:       8-K
Filed at:   2023-07-31T23:59:59+00:00
Accession:  0001193125-23-199108
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CSO Christopher Loose resigns; severance includes equity acceleration tied to Korro merger
--------------------------------------------------------------------------------

- Christopher Loose resigned as Chief Scientific Officer effective July 28, 2023.
- Severance includes 12 months base salary, COBRA coverage, and $201,744.35 target bonus.
- Unvested time-based equity awards accelerate only if proposed merger with Korro Bio closes by Dec 31, 2023.
- Separation agreement includes standard release of claims and non-disparagement obligations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1703647/000119312523199108/0001193125-23-199108-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1703647/000119312523199108/d533025d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-199108

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer